Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 4, 2008BloodOpen Access

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJames B. BusselDKDavid J. KuterVPVinod Pullarkat

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bussel et al. (2008) studied this question.

synapsesocial.com/papers/6a729cdffebe604dd70ab09fhttps://doi.org/10.1182/blood-2008-04-150078
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1How I treat idiopathic thrombocytopenic purpura (ITP)2005 · 357 citations
  2. 2Thrombopoietin Administered During Induction Chemotherapy to Patients With Acute Myeloid Leukemia Induces Transient Morphologic Changes That May Resemble Chronic Myeloproliferative Disorders2002 · 68 citations
  3. 3Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]1996 · 1,396 citations
  4. 4Circulating thrombopoietin level in chronic immune thrombocytopenic purpura1996 · 219 citations